HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
 Help
SONX [NYSE]
Sonendo, Inc.
Healthcare | Medical Devices | USA
statements
Index- P/E- EPS (ttm)-2.16 Insider Own10.10% Shs Outstand26.56M Perf Week2.10%
Market Cap38.34M Forward P/E- EPS next Y-1.50 Insider Trans-2.10% Shs Float21.84M Perf Month-21.93%
Income-57.10M PEG- EPS next Q-0.54 Inst Own59.20% Short Float2.00% Perf Quarter-46.72%
Sales37.40M P/S1.03 EPS this Y-3.90% Inst Trans-0.17% Short Ratio3.88 Perf Half Y-72.08%
Book/sh1.70 P/B0.86 EPS next Y29.10% ROA-66.10% Target Price5.08 Perf Year-
Cash/sh1.97 P/C0.74 EPS next 5Y51.80% ROE204.30% 52W Range1.40 - 12.24 Perf YTD-74.65%
Dividend- P/FCF- EPS past 5Y- ROI-44.90% 52W High-88.07% Beta-
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin25.00% 52W Low4.29% ATR0.17
Employees219 Current Ratio5.00 Sales Q/Q-31.80% Oper. Margin- RSI (14)34.94 Volatility11.72% 9.58%
OptionableNo Debt/Eq0.00 EPS Q/Q32.00% Profit Margin- Rel Volume0.91 Prev Close1.50
ShortableYes LT Debt/Eq0.59 EarningsAug 10 AMC Payout- Avg Volume112.80K Price1.46
Recom1.80 SMA20-18.73% SMA50-23.64% SMA200-69.76% Volume102,596 Change-2.67%
Jan-31-22Initiated Morgan Stanley Equal-Weight $6.90
Aug-13-22 08:34AM  
Sonendo, Inc. (NYSE:SONX) Just Reported Earnings, And Analysts Cut Their Target Price
Simply Wall St.
Aug-10-22 04:02PM  
Sonendo, Inc. Reports Second Quarter 2022 Financial Results
Business Wire +6.29%
Jul-19-22 08:00AM  
Sonendo, Inc. to Report Second Quarter 2022 Financial Results on August 10, 2022
Business Wire
Jul-05-22 08:00AM  
Sonendo, Inc. Welcomes Joanne Lindberg as Vice President of Sales, North America
Business Wire
Jun-17-22 08:30AM  
Sonendo, Inc. Announces Executive Management Team Changes
Business Wire -10.91%
May-24-22 11:00AM  
Sonendo, Inc. Names Crowe PR as Agency of Record
PR Newswire
May-19-22 05:58PM  
Sonendo, Inc. to Present at the Stifel Jaws and Paws Conference
Business Wire +8.30%
May-10-22 04:03PM  
Sonendo, Inc. Reports First Quarter 2022 Financial Results
Business Wire
May-05-22 07:49AM  
Great news for Sonendo, Inc. (NYSE:SONX): Insiders acquired stock in large numbers last year
Simply Wall St. -9.54%
Apr-27-22 08:00AM  
Sonendo, Inc. To Showcase Newly Launched CleanFlow Technology at 2022 AAE Annual Meeting
Business Wire
Apr-20-22 08:00AM  
Sonendo Announces Launch of CleanFlow Technology to Improve Doctor and Patient Experience
Business Wire +9.94%
Apr-19-22 04:03PM  
Sonendo, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, and Attend the 2022 Bank of America Healthcare Conference on May 11, 2022
Business Wire
Mar-24-22 04:05PM  
Sonendo, Inc. to Present at Piper Sandler & Co. Dental Day
Business Wire -15.88%
Mar-23-22 04:05PM  
Sonendo Inc. Reports Fourth Quarter 2021 Financial Results and Issues Full Year 2022 Revenue Guidance
Business Wire -8.67%
Mar-15-22 08:00AM  
Sonendo, Inc. Hits New Milestone of 800,000 GentleWave® Procedures, Demonstrating Continued Adoption and Growing Preference for Less Invasive Alternative to Traditional Root Canal Therapy
Business Wire +30.88%
Mar-02-22 04:02PM  
Sonendo, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 23, 2022
Business Wire -7.76%
Feb-03-22 12:44PM  
What Type Of Shareholders Own The Most Number of Sonendo, Inc. (NYSE:SONX) Shares?
Simply Wall St.
Jan-10-22 04:03PM  
Sonendo, Inc. Announces Preliminary Revenue Results for the Fourth Quarter and Full-Year 2021
Business Wire
Dec-09-21 04:02PM  
Sonendo Inc. Reports Third Quarter 2021 Financial Results and Issues Full Year 2021 Revenue Guidance
Business Wire
Dec-07-21 07:00AM  
Sonendo Appoints Raj Pudipeddi to Board of Directors
Business Wire +7.26%
Nov-18-21 04:03PM  
Sonendo, Inc. to Report Third Quarter 2021 Financial Results on December 9, 2021
Business Wire +5.93%
Nov-16-21 08:30AM  
Sonendo Announces Alma Salazar as Associate Vice President, Professional and Consumer Marketing
PR Newswire -10.00%
Nov-10-21 09:00AM  
Sonendo's GentleWave Surpasses 700,000 Treatments, Solidifying Procedure as Alternative to Traditional Root Canal Therapy
PR Newswire
Nov-03-21 04:05PM  
Sonendo Appoints Three New Members to Board of Directors
PR Newswire
04:05PM  
Sonendo Appoints Three New Members to Board of Directors
CNW Group
07:16AM  
4 Stocks Insiders Are Buying
Benzinga
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GENERAL ATLANTIC, L.P.DirectorAug 11Sale1.35366,808495,1912,900,938Aug 15 02:19 PM
Bergheim BjarnePresident and CEOJun 16Buy2.2528,50064,168979,349Jun 17 04:35 PM
Bergheim BjarnePresident and CEOJun 15Buy2.1716,50035,815950,849Jun 16 09:02 AM
Bergheim BjarnePresident and CEOJun 14Buy2.075,00010,364934,349Jun 16 09:02 AM
Bergheim BjarnePresident and CEOJun 01Buy2.751,8004,950929,349Jun 03 04:04 PM
Bergheim BjarnePresident and CEOMay 31Buy2.746,45217,647927,549Jun 02 04:45 PM
Bergheim BjarnePresident and CEOMay 25Buy2.6011,74830,551921,097May 26 08:07 AM
Pudipeddi Vamsi Mohan RajDirectorMay 25Buy2.6543,597115,53295,000May 26 08:07 AM
Pudipeddi Vamsi Mohan RajDirectorMay 24Buy2.681,4033,76051,403May 26 08:07 AM
Bergheim BjarnePresident and CEOMay 24Buy2.675,00013,363909,349May 25 04:03 PM
Smith Michael JohnChief Commercial OfficerMay 23Buy2.707,76920,998350,863May 25 04:02 PM
Bergheim BjarnePresident and CEOMay 23Buy2.7013,00035,103904,349May 24 04:07 PM
Bergheim BjarnePresident and CEOMay 18Buy2.6712,00032,059891,349May 20 07:10 PM
Bergheim BjarnePresident and CEOMay 17Buy2.7820,00055,600883,450May 19 09:04 AM
Bihl Anthony P IIIDirectorMay 17Buy2.9020,00058,00066,000May 19 09:03 AM
Smith Michael JohnChief Commercial OfficerMay 17Buy2.7316,46844,958362,857May 18 04:03 PM
Smith Michael JohnChief Commercial OfficerMay 16Buy3.005,00015,000346,389May 18 04:03 PM
Bihl Anthony P IIIDirectorMay 16Buy2.8515,00042,75046,000May 18 09:03 AM
Bergheim BjarnePresident and CEOMay 16Buy2.9530,00088,500863,450May 18 09:03 AM
Pudipeddi Vamsi Mohan RajDirectorMay 13Buy2.6550,000132,50050,000May 16 09:06 AM
Bihl Anthony P IIIDirectorMay 13Buy2.6715,00040,05031,000May 17 09:00 AM
Kirkpatrick Andrew JChief Operating OfficerMay 13Sale2.781,6594,611193,678May 17 07:06 PM
Watts Michael PatrickChief Financial OfficerMay 13Sale2.782,1295,917235,170May 17 07:06 PM
Collins Jacqueline ArnoldVP, General CounselMay 13Sale2.789332,593115,319May 17 07:04 PM
Smith Michael JohnChief Commercial OfficerMay 13Sale2.781,9585,441341,389May 17 07:04 PM
Chen Roy TChief Talent OfficerMay 13Sale2.781,0582,940119,844May 17 07:04 PM
Khakpour MehrezadChief Technology OfficerMay 13Sale2.782,4246,737235,720May 17 07:03 PM
Bergheim BjarnePresident and CEOMay 13Sale2.784,10111,397879,349May 17 07:02 PM
Watts Michael PatrickChief Financial OfficerFeb 10Option Exercise4.0210,00040,20060,400Feb 14 05:31 PM
Chen Roy TChief Talent OfficerNov 30Option Exercise4.022,2509,04527,250Dec 14 04:12 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do Not Sell My Data • Privacy Settings
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2022 FINVIZ.com. All Rights Reserved.